ALNY Overview - Alpha 52

α52

Alpha 52

Where AI meets Quant

Home
Stock
Hot Lists
Investments
Insights
Support

Overview Investment Metrics Trades News

ALNY

331.91

+ 0.65%

Signal: 76.0

Trending Up

Alnylam Pharmaceuticals, Inc.

Pharma & Biotech

Updated 2025-07-03 17:28:11 UTC

All content on this website, including but not limited to data, analyses, and forecasts, has been calculated and generated using mathematical, quantitative, and artificial intelligence models developed solely by the website owner. Accordingly, the website owner retains all intellectual property rights related to these models and their outputs. The content of this website does not constitute a recommendation and is provided for informational purposes only. The website owner is not providing any financial, economic, legal, investment, accounting, or tax advice through this website or to its recipient. Certain information contained in this website includes future expectations, and there is no guarantee that these results will be achieved. The owner has no obligation to provide updates or changes to the information on this website. The owner does not make any representation or warranty, expressed or implied, as to the accuracy or completeness of the statements or any information contained in this website, and any liability therefore, including in respect of direct, indirect, or consequential loss or damage, is expressly disclaimed. Past performance does not guarantee any future results.

Home Stock Hot Lists Investments Insights

Support

FAQ Coverage User Guide